Pre-T2D IPFP ASCs also demonstrated a robust increase (fold change >1000) in FOXG1 expression compared to Non-T2D IPFP ASCs in all experimental conditions, reaching significance after IL-1β stimulation. The gene discussed is FOXG1; the disease is type 2 diabetes mellitus.